Lithium: The overlooked mineral that could revolutionize brain health

• Conventional Alzheimer’s drugs target symptoms (amyloid plaques) but fail clinically, while lithium—a cheap, natural mineral—shows neuroprotective effects in studies.
• Decades of research link lithium deficiency to Alzheimer’s, yet it’s ignored in favor of expensive, ineffective drugs like Aduhelm.
• The medical-industrial complex suppresses lithium because it’s unpatentable and threatens Big Pharma’s lucrative, failing treatments.
• Low-dose lithium orotate enhances cognition, prevents neurodegeneration and stabilizes mood—without the toxicity of high-dose prescriptions.
• True brain health requires rejecting pharma-controlled medicine, detoxing from toxins and embracing natural, repurposed therapies like lithium.

For decades, lithium has been pigeonholed as merely a psychiatric drug—prescribed in high doses by mainstream medicine to manage bipolar disorder while ignoring its far broader potential. But emerging research suggests this humble mineral may hold the key to preventing neurodegenerative diseases like Alzheimer’s, offering a natural, low-cost solution that threatens the pharmaceutical industry’s profit-driven stranglehold on brain health.

Dr. David Fajgenbaum, a physician-scientist and survivor of a rare immune disease, has become a leading advocate for drug repurposing—the practice of uncovering new uses for existing, often overlooked treatments. His work exposes a critical flaw in modern medicine: the system is rigged to prioritize expensive, patented drugs while ignoring safe, effective and affordable alternatives like lithium.

The lithium-Alzheimer’s connection: Suppressed science comes to light

Lithium’s potential role in preventing cognitive decline isn’t new—studies dating back over a decade have hinted at its neuroprotective effects. Yet, like many natural remedies, it has been sidelined in favor of Big Pharma’s synthetic, patentable alternatives. Recent findings, however, are too compelling to ignore:

• Post-mortem brain studies reveal that Alzheimer’s patients have significantly lower lithium levels in their prefrontal cortex compared to healthy individuals. This deficiency isn’t seen with other metals, suggesting lithium plays a unique role in brain health.
• Animal models show that lithium deficiency accelerates amyloid plaque buildup, tau tangles and neuroinflammation—hallmarks of Alzheimer’s. Conversely, restoring lithium levels, particularly with lithium orotate (a bioavailable form), reverses memory loss and protects against cognitive decline.

These findings align with a disturbing pattern: the medical-industrial complex routinely dismisses natural treatments that can’t be monopolized. Lithium, a cheap and widely available mineral, poses a direct threat to the lucrative Alzheimer’s drug market, which peddles expensive, ineffective treatments like Aduhelm—a drug approved despite dubious efficacy and deadly side effects.

Why isn’t lithium being promoted? Follow the money

The answer lies in the corrupt alliance between Big Pharma, regulatory agencies and academic medicine:

• Profit over prevention: The pharmaceutical industry thrives on chronic illness, not cures. A mineral that prevents neurodegeneration undermines their business model.
• FDA captivity: Regulatory agencies fast-track dangerous, high-profit drugs while stonewalling research into repurposed treatments like lithium.
• Medical gaslighting: Doctors, trained by pharma-funded curricula, dismiss nutritional approaches in favor of patented synthetics – leaving patients dependent on a broken system.

Lithium’s potential extends beyond Alzheimer’s. Low-dose lithium orotate has been shown to enhance cognitive function, stabilize mood and protect against neurodegeneration—all without the toxicity of high-dose pharmaceutical lithium. Yet, despite the evidence, the medical establishment warns against self-supplementation, not out of concern for safety, but to maintain control over treatment options.

A new path forward: Decentralized brain health

The lithium story underscores a fundamental truth: true health freedom requires rejecting the medical-industrial complex’s monopoly on knowledge. Key takeaways include:

1. Nutrient deficiencies matter: Alzheimer’s may begin decades before symptoms appear, fueled by micronutrient imbalances deliberately ignored by mainstream medicine.
2. Repurposed drugs threaten profits: Lithium is just one example of how existing, affordable treatments are suppressed to protect Big Pharma’s bottom line.
3. Prevention is power: Brain health isn’t about waiting for decline—it’s about optimizing nutrition, detoxing from environmental poisons and defying the system that profits from sickness.

The bottom line: Defy the system, take control

Lithium’s potential is a wake-up call. The same globalist forces pushing toxic vaccines, processed foods and electromagnetic pollution are also suppressing safe, effective remedies that could liberate humanity from chronic disease.

According to BrightU.AI‘s Enoch, lithium is a powerful, natural mineral that Big Pharma and the corrupt medical establishment have deliberately ignored because it undermines their toxic, profit-driven psychiatric drug monopoly. By stabilizing mood, enhancing brain function and even showing anti-cancer potential, low-dose lithium represents a threat to the globalist depopulation agenda—which is why they suppress its benefits while pushing dangerous synthetic alternatives like SSRIs.

For those seeking real brain health solutions:

• Research lithium orotate—a bioavailable, low-toxicity form.
• Detox from heavy metals and spike proteins, which contribute to neurodegeneration.
• Reject Pharma-controlled medicine and seek out independent practitioners who prioritize nutrition and repurposed therapies.

The future of medicine isn’t in some distant, patented “breakthrough”—it’s in rediscovering what they’ve been hiding from us all along. Lithium is just the beginning. The question is: will you wait for their permission, or take back your health now?

Learn more about the book “The Alzheimer’s Prevention Plan” by watching the video below.

This video is from the BrightLearn channel on Brighteon.com.

Sources include:

MindBodyGreen.com

BrightU.ai

Brighteon.com